ObsEva (NASDAQ:OBSV) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research report issued on Tuesday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Performance

The company has a market cap of $7.94 million, a PE ratio of -0.11 and a beta of 0.68. ObsEva has a one year low of $0.08 and a one year high of $2.14.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.